Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
NCT ID: NCT01870219
Last Updated: 2013-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
24 participants
INTERVENTIONAL
2012-02-29
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
NCT02267980
Sevoflurane in Electroconvulsive Therapy
NCT01905904
The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy
NCT02271555
Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy
NCT02305394
Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy
NCT02500225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Electrical stimulus is delivered via bilateral frontotemporal electrodes.The mean arterial pressure (MAP), HR, and ECG are recorded before anesthetic induction (T1), after anesthetic induction (T2) and at 0, 1, 3, 10 min after the seizure ended (T3, T4, T5 and T6, respectively).The QT interval and Tp-e interval are measured by one author, who was unaware of group allocation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group S
In group S, sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered, at which time it was turned off.
Sevoflurane
sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered
Group K
In group K, ketamine was given to 1mg/kg ıv bolus.
Ketamine
ketamine was given to 1mg/kg ıv bolus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered
Ketamine
ketamine was given to 1mg/kg ıv bolus
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) I-II the patients
* Major depressions patients scheduled for ECT sessions
Exclusion Criteria
* with permanent pacemakers,
* diabetes mellitus,
* atrial fibrillation,
* electrolyte imbalance,
* patients taking antiarrhythmics and β-blockers.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Feray Erdil
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feray Erdil, MD
Role: PRINCIPAL_INVESTIGATOR
Associated Prof Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turgut Ozal Medical Center
Malatya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Erdil F, Demirbilek S, Begec Z, Ozturk E, Ersoy MO. Effects of propofol or etomidate on QT interval during electroconvulsive therapy. J ECT. 2009 Sep;25(3):174-7. doi: 10.1097/YCT.0b013e3181903fa5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Turgut Ozal Medical Center
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.